5,728
Views
207
CrossRef citations to date
0
Altmetric
Research Article

A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials

, , &
Pages 375-393 | Received 07 Nov 2010, Accepted 23 Dec 2010, Published online: 15 Apr 2011
 

Abstract

Background. Current treatment of hyperglycemia in type 2 diabetes (T2DM) is often ineffective and has unwanted effects. Therefore, novel antidiabetic drugs are under development.

Objective. To assess efficacy and safety of the new antidiabetic drugs sodium glucose co-transport-2 (SGLT2) inhibitors in T2DM.

Design and setting. Among 151 articles published on MEDLINE, Cochrane Library, EMBASE, PubMed, International meeting abstracts through December 2010, 13 randomized placebo-controlled trials (RCT) were included.

Measurements. Two reviewers retrieved articles and evaluated study quality by appropriate scores. Main outcomes were pooled using random- or fixed-effects models.

Results. Dapagliflozin significantly reduced HbA1c (weighted mean difference (WMD) −0.52%; 95% CI −0.46, −0.57%; P < 0.00001) fasting plasma glucose (WMD −18.28 mg/dL; 95% CI −20.66, −15.89; P < 0.00001), body mass index (WMD −1.17%; −1.41, −0.92%; P < 0.00001), systolic (WMD −4.08 mmHg; −4.91, −3.24), and diastolic (WMD −1.16 mmHg; −1.67, −0.66) blood pressure, and serum uric acid (WMD −41.50 μmol/L; −47.22, −35.79). Other SGLT2 inhibitors showed similar results. Dapagliflozin treatment increased the risk of urinary (OR 1.34; 1.05–1.71) and genital (OR 3.57; 2.59–4.93) tract infection; it also mildly increased the risk of hypoglycemia (OR 1.27; 1.05–1.53) when co-administered with insulin.

Limitations. Limitations of the literature include the small number, size, and duration of RCTs.

Conclusions. Pending confirmation from larger RCTs, this analysis shows SGLT2 inhibitors are safe and effective for hyperglycemia treatment in T2DM.

Acknowledgements

Role of each author: Giovanni Musso: data collection and elaboration, statistical analysis and writing of the manuscript. Roberto Gambino: data collection and discussion, and review of the manuscript. Maurizio Cassader: data collection and discussion, and review of the manuscript. Gianfranco Pagano: data collection and discussion, and writing of the manuscript.

Declaration of interest: No author has any present or past conflict of interest to report. All authors are independent of any commercial funder; Giovanni Musso takes responsibility for the integrity of the data and the accuracy of the data analysis. This work was supported in part by the Piedmont Region Funds Comitato Interministeriale per la Programmazione Economica 2008, which were employed for data collection.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.